Scale -


  • Revenue is 405 Rs Cr; in Top Quartile
  • PBT is 10.44 Rs Cr; in Top Quartile
  • Quarterly Revenue is 111 Rs Cr; in Top Quartile
  • Quarterly Ebitda is 7.37 Rs Cr; in Top Quartile
  • Quarterly Profit is 8.62 Rs Cr; in Top Quartile

Profitability -


  • PBDIT Margin is 2.39 %; in Bottom Quartile

Return -


  • ROCE is 22.03 %; in Top Quartile
  • ROA is 0.12 %; in Bottom Quartile
  • Asset Turnover is 0 %; in Bottom Quartile

Efficiency -


  • Current Ratio is 1.03; in Bottom Quartile
  • Inventory Turnover Ratio is 0; in Bottom Quartile
  • Operating cash flow is -1135 Rs Cr; in Bottom Quartile

Solvancy -


  • Debt/Equity is 26.01; in Top Quartile
  • Total Debt is 1141 Rs Cr; in Top Quartile

Quality -


  • Change in Inventories/Total Expenses is -33 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 2 %; in Bottom Quartile
  • Operating cashflow/ebitda is -117 %; in Bottom Quartile
  • Operating cashflow/PAT is -533 %; in Bottom Quartile
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Current Tax/PAT is 106 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Remedium Lifecare Ltd Rights 2025- For Shares Estimates – BSE:SUPHA_RE
Enterprise value to EBITDA forward of Remedium Lifecare Ltd Rights 2025- For Shares – BSE:SUPHA_RE